What the business is, and whether it's a good one at a fair price.
Operates in the investment and trading space, with a balance sheet of Rs 31.976 crore in total assets as of FY26. The company earns revenue from its investment and trading activities — Rs 1.6029 crore in FY26, producing a net profit of Rs 0.1505 crore. Quarterly income is highly uneven, with Q3 FY26 at Rs 8.60 lakh versus Rs 77.56 lakh in the year-ago quarter, indicating lumpy, transaction-driven realizations rather than a recurring income stream. The cost base is small, with employee costs at 12.8% of revenue and other operating expenses at 12.0%, while materials and capex are negligible. Equity stands at Rs 3,187.63 lakh, almost the entire Rs 3,197.60 lakh asset base. The filings do not detail what specific instruments or assets the company invests in or trades; they confirm only that the entity operates in this space.
Measured from the filed financials, judged against its Other Financial Services peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Symbiox Investment & Trading C's filed financials and exchange disclosures
Symbiox Investment & Trading C is a Finance company listed on BSE.
Yes. Over the trailing twelve months Symbiox Investment & Trading C reported a net profit of ₹0 Cr on revenue of ₹1 Cr.
Not in the latest reported year — Symbiox Investment & Trading C's dividend payout for FY26 was nil.
Effectively yes. It holds ₹0 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, Symbiox Investment & Trading C ranks 75 of 95 in Other Financial Services — cheaper than 21% of them, against an industry median of 17.9×. This is a position, not a valuation judgement.
On a typical session Symbiox Investment & Trading C moves 2.89% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Symbiox Investment & Trading C appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
